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Obesity, resulting from energy imbalance caused by an increased ratio of  caloric intake to energy expenditure is a 
global health problem. This study investigated the effects of  Sorghum bicolor leaf  extracts (SBE) on blood lipid 
levels in high fat diet-induced obese rats. Sorghum bicolor leaf  was extracted with 70% ethanol using Soxhlet 
extractor. Male Wistar rats (n=36) divided into six groups: (A) normal control, (B) obese control (High Fat Diet – 
HFD), (C) HFD+150 mg/kg body weight SBE (first treatment), (D) HFD+300 mg/kg body weight SBE 
(second treatment), (E) HFD+600 mg/kg body weight SBE (third treatment) and (F) HFD+ 1200 mg/kg body 
weight SBE (fourth treatment) were used. The SBE was administered orally to the animals daily for 28 days. Body 
weight was taken weekly and Lee index was calculated alongside. Plasma, erythrocytes and lipoproteins' lipid 
profiles were determined using spectrophotometric methods. Results from the study revealed that generally, 
SBE significantly reduced (p<0.05) the levels of  cholesterol, phospholipids, triacylglycerol by varying levels, in 
the various blood compartments of  the obese animals.  It was observed that SBE caused a significant (p<0.05) 
decrease in plasma cholesterol level of  the fourth treatment group. Also, SBE significantly (p<0.05) reduced the 
elevated atherogenic and coronary risk indices by 50%. This study suggests that SBE might be useful in the 
management of  obesity and its co-morbid conditions.
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INTRODUCTION
Obesity is a chronic condition in which the 
adipose tissue mass is increased and leads to 
increase in body weight due to accumulation of  
fat. It is a global health problem of  the 21st 
century which results from energy imbalance 
caused by an increased ratio of  caloric intake to 
energy expenditure (Ramgopal et al., 2010). In 
developing countries, the prevalence of  obesity is 
rising continuously, and is now occurring even at 
younger ages (Greenberg and Obin, 2006). The 
accumulation of  fat is essentially the only way 
body weight becomes excessive, especially as the 
other energy storage tissues like the muscle and 
liver do not have the potentials of  the adipose 
tissue to exceed requirement limits (Sikaris, 2004). 
The adipose tissue is the storage tissue for 
triacylglycerol and also an endocrine organ which 
releases chemical messengers called adipokines 
used for communication with other tissues 
thereby controlling metabolic functions (Kershaw 
and Flier, 2004). Obesity is usually defined by 
Body Mass Index (BMI), which equals person's 
weight in kilograms (kg) divided by the height in 
2
meters square (m ), with values greater than 29.9 
considered obese (Greenberg and Obin, 2006). 
According to WHO report (2013), about 2.8 
million adults die due to being overweight and /or 
obese. Also, 44% of  diabetic patients, 23% of  
ischemic heart problem and 7% to 41% cases of  
endometrial, breast and colon cancers have been 
attributed to overweight and obesity (WHO, 
2013). Many factors interact at diverse levels to 
influence energy balance; therefore, determining 
the etiology and developmental changes leading 
to obesity is cumbersome (Bray and Popkin, 
1998). As far back as 1983, Hartz et al. (1983), in 
their studies, observed that obesity is associated 
with dyslipidemia, atherosclerosis, type 2 diabetes, 
hypertension, hypercholesterolemia, heart attack 
and osteoarthritis. Besides these hazards, obesity 
is also associated with infertility in males, 
polycystic ovary syndrome and breast cancer in 
females (Vanltallie, 1992). Though, the 
interaction of  genetics and environmental factors 
is the most accepted model for obesity, the relative 
importance of  these two factors varies across 
populations (Bouchard and Perusse, 1993). 
Amongst the causes of  obesity, the most 
important has been linked to diet (Jyothsna1 and 
Kumar, 2015). This is because the intake of  high 
fat diet and high carbohydrate foods tend to 
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increase weight (Bleich et al., 2008). Also in 
children, decreased physical activity and increased 
energy intake (as sugar or fat) has been linked to 
obesity (Butte, 2000; Robinson, 2001). Induction 
of  obesity using high fat diets in animal models has 
been recognized and diet-induced obesity known 
as “DIO” animal models which is used in 
investigating obesity outcomes is used as a 
resemblance for human obesity, though DIO 
models differ in macronutrient composition 
(Thibault et al., 2004). The macronutrient 
composition of  DIO models differ irrespective of  
the percentage contribution of  fat to energy in the 
diet; fatty acid composition plays a significant role 
in body weight regulation, although, all fat are not 
equally obesogenic (Kien et al., 2005). 
Saturated fatty acids are stored in the adipose 
tissue rather than being used as fuel, whereas, 
monounsaturated fatty acid (MUFA) and 
polyunsaturated fatty acid (PUFA) are mainly used 
as fuel (Moussavi et al., 2008). There is evidence 
that saturated fatty acid (SFA) intake is positively 
correlated with obesity (van Dijk et al., 2009; 
Phillips et al., 2009). However, monounsaturated 
fatty acid (MUFA) intake reduces the impact of  a 
high fat diet on obesity (Bos et al., 2010; Lai et al., 
2009). It has also been suggested that fatty acids 
and their composition influence the biological 
characteristics of  adipocytes (van Dijk et al., 2009).
Factors such as periodic feeding, circadian rhythm 
and pattern of  feed intake, size, frequency and 
duration of  meals, intermeal interval, satiety ratio 
and the rate of  feeding have been reported to play 
a significant role in the development of  obesity in 
rodents and humans (Chapelot et al., 2006; Arble et 
al., 2009). High fat diets have been reported to 
induce alterations in eating pattern (Bellisle, 2004; 
Savastano and Covasa, 2005). This alteration was 
linked to larger meal sizes due to low intra-meal 
satiety signals, decrease in sensitivity to food 
intake-lowering effect of  cholecystokinin and less 
control over appetite due to infrequent meals 
which lead to higher energy intake (Bellisle, 2004; 
Savastano and Covasa, 2005). Feeding at different 
circadian time other than the normal nocturnal 
feeding time has been associated with high risk of  
obesity in rodents as well as humans (Ma et al., 
2003; Arble et al., 2009). The expression of  clock 
genes like Clock and Bmal 1 in the hypothalamus 
and in other cells of  the body, affect physiological 
activities such as eating, lipid and glucose 
metabolism (Rudic et al., 2004). High fat diets and 
obesity attenuate the expression of  these clock 
genes in the liver and adipose tissue, hence they 
affect metabolism and body weight balance 
(Rudic et al., 2004). In obesity, there is an increase 
in the release of  whole body free fatty acid and 
glycerol from adipocytes due to deficiency of  
perilipins which prevent lipases from hydrolyzing 
triacylglycerols to facilitate free fatty acid release 
(Zhang et al., 2003). Proinflammatory factors like 
interleukin 6, TNF-α, tissue factor nitric oxide 
synthase are produced in the adipose tissue as 
obesity increases; also macrophages are increased 
with obesity where they effect the production of  
cytokines in the adipose tissue (Greenberg and 
Obin, 2006). These inflammatory factors 
promote free fatty acid release from adipose tissue 
into blood stream to act on other tissues such as 
the liver and muscle and consequently result in 
systemic insulin resistance, thus adipose tissue 
inflammation is associated with obesity-related 
complications (Greenberg and Obin, 2006).  
Obesity increases VLDL (triacylglycerols) 
through increased production and decreased 
clearance of  triacylglycerol rich lipoproteins due 
to lack of  stimulation of  lipoprotein lipase; and 
also lowers HDL in men and women of  all ages 
(Sikaris, 2004). Plasma lipid dynamics have been 
widely studied during various metabolic 
malfunctions due to their involvement in vascular 
disorders (Rotimi et al., 2015). The lipid 
composition of  erythrocytes is presently 
becoming of  great interest as the aetiology of  
many diseases has been linked to erythrocyte lipid 
abnormalities (Allen and Manning, 1994). Several 
studies have shown that erythrocyte lipid is 
composed mostly of  unesterified (free) 
cholesterol, phospholipids and little cholesterol 
esters which are different from that of  the plasma 
environment (Suda et al., 2002). Despite this 
difference in the lipid composition of  the 
erythrocyte and its plasma environment, 
circulating mature erythrocytes from mammals 
are limited in their lipid metabolism and there is 
little or no evidence of  de novo synthesis of  lipid by 
the erythrocyte (Rotimi et al., 2015). Also, in vivo 
and in vitro evidences have suggested that one of  
the major pathways for replacement of  
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erythrocyte lipids is through exchange with plasma 
lipids (Rotimi et al., 2015). For instance, a rapid rate 
of  exchange of  lipids between HDL and 
erythrocytes has been reported (Nikolic et al., 
2004; 2007; Meurs et al., 2005). 
Obesity has been managed and treated by weight-
loss programs involving dietary changes, exercise 
and activity, behavioural changes, weight-loss 
prescriptions and on rare cases, weight-loss 
surgery (Shick et al., 1998; Stoppler, 2012). In some 
researches using laboratory animals like rats, ad 
libitum low-fat diets caused weight loss and 
reversed dietary obesity, while in other studies, the 
approach was inefficient (Wade, 1983; Huang et al., 
2004). The use of  traditional medicines and/or 
medicinal plants as a cheap remedy accessible to all 
and as therapeutic agents for the maintenance of  
good health in developing countries has been 
reported (UNESCO, 1998). Reports showed that 
about 80% of  the population of  developing 
countries relies on traditional medicines for their 
primary health care (Schmincke, 2003). Various 
parts of  these medicinal plants which include 
leaves, stems, flowers, fruits, barks and roots, are 
used in the preparation of  decoctions (Schmincke, 
2003). Amongst these medicinal plants, is Sorghum 
bicolor (Linn.) Moench - a tropical cane-like grass, 
belonging to the family Poaceae plant (Odugbemi, 
2008). According to previous research, Sorghum 
bicolor leaf  sheath is a rich source of  
phytochemicals which are tannins, saponins, 
simple phenolic acids, flavonoids, alkaloids, 
anthocyanins, phytosterols, and policosanols. 
Some of  these bioactive components have been 
reported to have antioxidants (Kim et al., 2010; 
Sikwese and Duodu 2007). Awika and Rooney 
(2004) reported that the consumption of  S. bicolor 
reduced the risk of  cancer in humans compared to 
other cereals and also promoted cardiovascular 
health in animals. Tannins in S. bicolor are widely 
reported to decrease caloric availability and hence 
reduce weight gain in animals, indicating its 
potential in reducing obesity in humans (Awika 
and Rooney, 2004). Tsuda (2003) reported the 
inhibitory effect of  anthocyanins extracted from 
S. bicolor on increases in both body weight and 
adipose tissue weight of  rats consuming high-fat 
diets. Also, extracts of  S. bicolor leaf  sheath have 
been reported to possess antilipidemic activity 
(Chung et al., 2010). 
Therefore, this study was conducted to investigate 
the possibility of  managing dyslipidemic 
complications associated with obesity using 
Sorghum bicolor leaf  extract (SBE) in high fat diet-
induced obese rats.
MATERIALS AND METHODS
Collection and Authentication of  Plant
Bundles of  Sorghum bicolor leaf  sheath were 
purchased from Rukayat herbarium in Abeokuta, 
Ogun state. The bundles were authenticated by 
Dr. O. R. Adeyemi, a Weed Scientist and Dr. A. S. 
Oyelakin, a taxonomist in the Federal University 
of  Agriculture, Abeokuta where a voucher 
specimen was deposited (Voucher No: 
FUNAABH 0021).
Preparation of  Plant Extract
The bundles of  Sorghum bicolor were rinsed in clean 
water and thereafter air-dried in the laboratory. 
The dried plant was pulverized and extracted with 
70% ethanol using a Soxhlet extractor, Thermo 
scientific model, UK. The extract obtained was 
concentrated using a rotary evaporator and then 
air-dried to obtain a solid powdery mass which 
was dissolved in distilled water for oral 
administration to experimental animals.  
Animals
Thirty-six young male Wistar rats (5-6 weeks old) 
weighing 50±10g were used. They were housed in 
cages under ambient conditions and allowed to 
acclimatize for two weeks before commencement 
of  obesity induction using high fat diet. All 
procedures used followed the Principles of  
Laboratory Animal Care from NIH Publication No. 
85-23 and were approved by the Ethics 
Committee of  the College of  Natural Sciences, 
Federal University of  Agriculture, Abeokuta, 
Ogun State, Nigeria. 
Phytochemical Analysis of  Plant Extract
Quantitative determination of  phytochemicals in 
the Sorghum bicolor leaf  was carried out according 
to the methods described for saponins (Brunner, 
1984), tannins (Swain, 1979), phenols (AOAC, 
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1984), alkaloids (Henry, 1973) and flavonoids 
(Adeyemi and Olorunsanya, 2012).
EXPERIMENTAL DESIGN
Induction of  Obesity and Treatment 
Protocol
The animals were divided into 6 groups consisting 
of  6 animals each. Group A served as the normal 
control and was fed with normal diet throughout 
the experiment; while the remaining animals were 
fed ad libitum with high fat-diet to induce obesity 
(Tuzcu et al., 2011). They were fed this diet 
continuously for twenty-five weeks and were 
judged obese with the use of  Lee index, defined 
by the body weight of  the animal in grams divided 
by the naso-anal length in centimeters (Bernadis 
and Patterson, 1968). Rats with the Lee index of  
 
Table 1: Composition of  diets in g/Kg.
Constituents       
 
Normal diet
 
High fat diet
 
Casein 
 
Starch 
Sucrose 
Corn oil 
Beef  tallow 
Cellulose 
Vitamin-Mineral Mix          
DL-Methionine   
 
Choline chloride                 
200
 
615 
- 
80 
- 
50 
50 
3
 
2
200
 
145  
150  
-  
400  
50  
50  
3
 
2
The vitamin-mineral mix is made up of   all-trans-
retinyl acetate, 1.8 mg; cholecalciferol, 0.025 mg; 
all-rac-a-tocopherol acetate, 12,5 mg; menadione 
(menadione sodium bisulfate), 1.1 mg; riboflavin, 
4.4 mg; thiamine (thiamine mononitrate), 1.1 mg; 
vitamin B-6, 2.2 mg; niacin, 35 mg; Ca-
pantothenate, 10 mg; vitamin B-12, 0.02 mg; folic 
acid, 0.55 mg; d-biotin, 0.1 mg. manganese (from 
manganese oxide), 40 mg; iron (from iron sulfate), 
12.5 mg; zinc (from zinc oxide), 25 mg; copper 
(from copper sulfate), 3.5 mg; iodine (from 
potassium iodide), 0.3 mg; selenium (from sodium 
selenite), 0.15 mg; choline chloride, 175 mg.
Thereafter, the obese rats were distributed 
according to their Lee index into five groups. 
Group B served as the obese control group and 
was fed only high-fat diet (HFD) throughout the 
experiment while groups C to F were orally 
administered daily with Sorghum bicolor leaf  extract 
(SBE) while also still on HFD for the rest of  the 
experiment. The animals in groups C to F were 
administered 150 mg/kg (first treatment), 300 
mg/kg (second treatment), 600 mg/kg (third 
treatment) and 1200 mg/kg body weight SBE 
(fourth treatment) respectively.
Determination of  Body Weight
Body weights of  animals were determined once a 
week using a measuring scale and the change in 
body weight was noted. Lee index of  each rat was 
also calculated.
Sample Collection
After four weeks of  extract administration, the 
animals were sacrificed after an overnight fast 
under light ether anaesthesia.  Blood was drawn 
from the animals through cardiac puncture into 
heparinized tubes and the plasma was separated 
from the erythrocytes by centrifuging the whole 
blood at 3500 rpm for 10 minutes. The 
erythrocytes were washed thrice with normal 
saline to remove extraneous materials. 
Biochemical Analyses
Separation of  HDL Fraction of  Plasma
The HDL fraction of  the plasma was separated 
after very low density lipoprotein (VLDL) and 
low density lipoprotein (LDL) were precipitated 
using heparin-MnCl  solution (Gidez et al., 1982). 
2
Heparin-manganese chloride solution (1 volume) 
was added to 10 volume of  plasma in a test tube. 
The resultant mixture was thoroughly mixed and 
o
allowed to stand at 25 C for 10 min. It was then 
centrifuged at 4000 rpm for 10 min. The 
supernatant was decanted into Eppendorf  tubes 
and stored in the refrigerator until further 
analysis.
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Extraction of  Lipids from Plasma, HDL and 
VLDL+LDL Fractions 
Plasma, HDL and VLDL+LDL lipids were 
extracted using chloroform-methanol mixture 
(2:1, v/v) (Folch et al., 1956). Aliquot (0.1 ml) of  
the plasma and HDL fraction were measured into 
test tubes and 0.9 ml chloroform-methanol 
mixture was added. The mixture was mixed 
o
thoroughly and allowed to stand at 25 C for 30 
min.  The mixture was then centrifuged at 4000 
rpm for 10 min. The chloroform layer was 
removed into a separate tube with a Pasteur's 
pipette. The VLDL+LDL precipitate was first 
returned to the original volume of  plasma from 
which HDL had been precipitated with 0.1M 
phosphate buffer pH 7.4, before the extraction 
process was carried out. 
Extraction of  Lipids from the Erythrocyte
Chloroform-isopropanol mixture (7:11 v/v) was 
used to extract lipids from the erythrocytes (Rose 
and Oklander, 1965). To 0.1 ml of  the washed 
erythrocytes, 0.9 ml chloroform-isopropanol 
mixture (7:11, v/v) was measured into test tube, 
mixed and left to stand for 1 hour for complete 
extraction of  lipids. The suspension was then 
centrifuged at 4000 rpm for 10 min and the 
supernatant containing the lipid was removed 
o
using Pasteur's pipette and stored at -4 C till 
further analysis.
D e t e r m i n a t i o n  o f  C h o l e s t e r o l ,  
Tr iacy lg l ycer o l  and  Phospho l ip ids  
Concentrations
The concentrations of  cholesterol in the plasma 
and HDL were determined using commercially 
available diagnostic kits. To determine cholesterol 
concentrations in VLDL+LDL and erythrocytes, 
0.1 ml of  the lipid extracts were evaporated to 
o
dryness at 50 C. For erythrocyte cholesterol 
determination, 20 μl of  Triton X- 100 : 
chloroform mixture (1:1, v/v) was added to the 
dried extract and this was evaporated again. Then 
1.0 ml of  the cholesterol kit reagent was added, 
mixed and incubated for 30 min before reading the 
absorbance at 505nm against a reagent blank. 
Triacylglycerol concentrations were also 
determined in the plasma and HDL using 
commercially available diagnostic kits. To 
determine triacylglycerol concentrations in 
VLDL+LDL and erythrocytes, 0.1ml of  the lipid 
extracts were evaporated and 0.1 ml of  97% 
ethanol was added to re-suspend the dried lipid 
extract. To this, 1.0 ml of  the triacylglycerol kit 
reagent was added, mixed and incubated for 30 
minutes before the absorbance was read against a 
reagent blank at 505 nm. 
Determination of  phospholipid concentration 
was  assessed us ing 0 .1N ammonium 
ferrothiocyanate (Stewart, 1979). Aliquots of  the 
lipid extracts of  plasma, HDL, VLDL-LDL and 
erythrocytes (0.1 ml) were evaporated to dryness 
o
at 50 C. After cooling, 2 ml chloroform was added 
to each of  the dried extract, mixed by inversion 
and 2 ml of  ammonium ferrothiocyanate was 
then added and mixed by inversion for 1 minute. 
The mixture was left for 10 min for separation to 
occur. The chloroform layer was later removed 
into a glass cuvette and the absorbance was read at 
488nm against a reagent blank. 
Estimation of  VLDL - and LDL – Cholesterol 
Concentrations
The concentrations of  VLDL-cholesterol and 
LDL-cholesterol were calculated by modification 
of  Friedewald's formulae (Sandkamp et al., 1990). 
VLDL-cholesterol (mg/dl) =  Triacylglycerol (mg/dl)
                            5                    
LDL-cholesterol (mg/dl) = Total plasma 
cholesterol  (HDL-cholesterol + VLDL- 
cholesterol).
Estimation of  Atherogenic and Coronary 
Risk Indices
Atherogenic index was calculated as the ratio of  
LDL-cholesterol and HDL-cholesterol while 
Coronary risk index was estimated as the ratio of  
plasma total cholesterol and HDL-cholesterol as 
described by Ademuyiwa et al. (2008).
Statistical Analysis
Results are expressed as mean ± S.E.M. One-way 
Analysis of  Variance (ANOVA) followed by 
Tukey's test was used to analyze the results with p 
< 0.05 considered significant. Relationships 
among the parameters were assessed by using 
Pearson's correlation.
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RESULTS
Table 2 shows the levels of  phytochemicals in 
SBE. SBE contained 11.5g/100g phytochemicals. 
Alkaloids, flavonoids, tannins, saponins and 
phenols make up 15%, 26%, 19%, 31% and 8% 
respectively. The quantity of  phytochemicals in 
decreasing order is Saponins > Flavonoids > 
Tannins > Alkaloids > Phenols.
Table 2: Levels of  phytochemicals in SBE
Phytochemical
 
Composition (g/100g)
 
Alkaloids                  1.78  
Flavonoids                 2.98  
Phenols                  0.96  
Saponins
                  
3.62
 
Tannins 2.16
Table 3: Body weight gain (g) and Lee indices
A      45.40±1.78
b            0.30±0.00
a   0.28±0.00
a  
B      70.00±0.45
d
  0.32±0.00
b
  0.31±0.00
b
 
C   35.00±1.58
a
  0.31±0.00
b
  0.29±0.00
a
 
D     64.00±1.58
e
  0.31±0.00
b
  0.29±0.00
a
 
E     55.00±2.24
c
  0.32±0.00
b
  0.29±0.01
a
 
F     46.00±1.76
b
  0.31±0.00
b
  0.29±0.02
a
 
Group                Body Weight gain(g)      Initial Lee index              Final Lee index                    
Values are mean ± S.E.M (n=6). Values in the column with different superscripts are significantly 
different from one another at p < 0.05. (A = Normal Control, B = Obese control,   C = 
HFD+150mg/kg body weight SBE (First treatment), D = HFD+300mg/kg body weight SBE (Second 
treatment), E = HFD+600mg/kg body weight SBE (Third treatment), F = HFD+1200mg/kg body 
weight SBE (Fourth treatment)). 
Weight gain and Lee index of  the animals are 
presented in Table 3. There was a significant (p < 
0.05) increase of  43% in the weight gain of  the 
obese control (group B) over that of  the normal 
control (group A). SBE reduced the weight gain of  
the treated groups by 50%, 9%, 21% and 34% in 
groups C, D, E and F respectively compared with 
group B. SBE lowered the Lee index of  the 
animals to an insignificant (p > 0.05) value which 
was not different from that of  group A, the 
normal control.
Figs. 1-2 depict cholesterol levels in the plasma, 
erythrocyte and the lipoproteins. Plasma 
cholesterol level of  group B was the highest and it 
was significantly different (p < 0.05) from the 
values obtained for the treated groups with 8%, 
9%, 11% and 35% for groups C, D, E and F 
respectively. SBE elevated the HDL-cholesterol 
level of  the treatment groups by 3-fold that of  
group B. Also, SBE reduced the LDL- cholesterol 
level of  the treated groups by 60% in groups C 
and D, 54% and 75% in groups E and F when 
compared with group B.  A significant (p < 0.05) 
increase of  46% in the VLDL-cholesterol level of  
group B in comparison with group A was 
observed. SBE reduced the VLDL-cholesterol 
concentration between 1.4% and 29% in the 
treatment groups. Erythrocyte cholesterol 
concentration of  group B was 3-fold that of  
group A. SBE reduced the cholesterol 
concentrations of  the obese rats by 23% - 57%. 
Erythrocyte cholesterol levels of  the treatment 
groups were however still significantly (p<0.05) 
higher than that of  group A by 27% - 130%. The 
treatment group E administered 1200 mg/kg 
body weight SBE was the most efficient.           
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Plasma, erythrocyte and lipoprotein triacylglycerol 
levels are depicted in Figs. 3-4. There was a 
significant increase (p < 0.05) of  60% in the total 
triacylglycerol level of  group B when compared 
with group A. Administration of  SBE reduced the 
total triacylglycerol level by 30%, 8%, 22% and 
36% for groups C, D, E and F respectively in 
comparison with group B. A 1.74-fold increase 
was observed in the HDL-triacylglycerol level of  
group C with oral administration of  150 mg/kg 
body weight SBE. In addition, SBE reduced the 
VLDL+LDL-triacylglycerol level by 56%, 48%, 
47% and 69% in groups C, D, E and F accordingly 
when compared with group B. The fourth 
treatment proved to be the best treatment. 
Erythrocyte triacylglycerol concentration of  
group B was 1.4-fold higher than group A. SBE 
reduced the triacylglycerol concentration of  the 
obese rats by 5% to 36%.
 
Fig. 1. Cholesterol Concentrations in Plasma and Erythrocyte of  the Animals. 
Bars carrying different letters of  the alphabet are significantly different from each other at p < 0.05. (A = 
Normal Control, B = Obese control,   C = HFD+150mg/kg body weight SBE (First treatment), D = 
HFD+300mg/kg body weight SBE (Second treatment), E = HFD+600mg/kg body weight SBE 
(Third treatment), F = HFD+1200mg/kg body weight SBE (Fourth treatment)).
Fig. 2. Cholesterol Concentrations in the Lipoproteins of  the Animals. 
Bars carrying different letters of  the alphabet are significantly different from each other at p < 0.05. (A = 
Normal Control, B = Obese control,   C = HFD+150mg/kg body weight SBE (First treatment), D = 
HFD+300mg/kg body weight SBE (Second treatment), E = HFD+600mg/kg body weight SBE 
(Third treatment), F = HFD+1200mg/kg body weight SBE (Fourth treatment).
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In Figs. 5-6, plasma, erythrocyte and lipoproteins 
phospholipid level are depicted. Significant 
increase of  320% and 89% were obtained in the 
plasma and VLDL+LDL-phospholipids levels of  
group B when compared with group A. In the 
HDL-phospholipids, a significant (p<0.05) 
reduction of  46% was observed in group B 
compared with group A. SBE decreased the total 
phospholipid level by 4.84, 2.28, 1.34 and 1.09 fold 
in groups C, D, E and F accordingly, when 
compared with group B. The level of  HDL- 
phospholipid was increased by 39%, 85%, 115% 
and 81% in groups C, D, E and F respectively in 
comparison with group B. Moreover, SBE 
diminished the VLDL+LDL-phospholipids level 
by 33%, 36%, 40% and 38% in groups C, D, E and 
F respectively when compared with group B. 
Erythrocyte phospholipid concentration of  
group B was 1.6-fold higher than that of  group A. 
SBE reduced the phospholipid concentrations of  
the obese rats by 11% to 41% when compared 
with group B. 
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Fig. 3. Triacylglycerol Concentrations in Plasma and Erythrocyte of  the Animals. 
Bars carrying different letters of  the alphabet are significantly different from each other at p < 0.05. (A = 
Normal Control, B = Obese control,   C = HFD+150 mg/kg body weight SBE (First treatment), D = 
HFD+300 mg/kg body weight SBE (Second treatment), E = HFD+600 mg/kg body weight SBE 
(Third treatment), F = HFD+1200 mg/kg body weight SBE (Fourth treatment)).
Fig. 4. Triacylglycerol Concentrations in the Lipoproteins of  the Animals. 
Bars carrying different letters of  the alphabet are significantly different from each other at p < 0.05. (A = 
Normal Control, B = Obese control,   C = HFD+150 mg/kg body weight SBE (First treatment), D = 
HFD+300 mg/kg body weight SBE (Second treatment), E = HFD+600 mg/kg body weight SBE 
(Third treatment), F = HFD+1200 mg/kg body weight SBE (Fourth treatment)).
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Fig.  7 present the coronary risk and atherogenic 
indices of  the animals. Group B had a value thrice 
that of  group A. The extract brought about a 
decrease in the coronary risk index of  the 
treatment groups by 65% in group C, 70% in 
group D and E, while the percentage reduction in 
group F was 76% when compared with group B. 
The values obtained for groups C, D, E and F were 
significantly (p<0.05) similar to the value obtained 
for group A. SBE had the same effect on the 
atherogenic index of  the animals. Group B had an 
atherogenic index that was 4-fold that of  group A. 
Administration of  SBE significantly lowered the 
index to values lesser than that of  group A (45%, 
47%, 64% and 90% for groups C, D, E and 
respectively). The most efficient treatment was 
however the fourth treatment which reduced the 
coronary risk and atherogenic indices drastically.
Table 4 presents intensity of  associations between 
body weight gain, atherogenic and coronary risk 
Fig. 5. Phospholipid Concentrations in Plasma and Erythrocyte of  the Animals. 
Bars carrying different letters of  the alphabet are significantly different from each other at p < 0.05. (A = 
Normal Control, B = Obese control,   C = HFD+150 mg/kg body weight SBE (First treatment), D = 
HFD+300 mg/kg body weight SBE (Second treatment), E = HFD+600 mg/kg body weight SBE 
(Third treatment), F = HFD+1200 mg/kg body weight SBE (Fourth treatment)).
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Fig. 6. Phospholipid Concentrations in the Lipoproteins of  the Animals. 
Bars carrying different letters of  the alphabet are significantly different from each other at p < 0.05. (A = 
Normal Control, B = Obese control, C = HFD+150 mg/kg body weight SBE (First treatment), D = 
HFD+300 mg/kg body weight SBE (Second treatment), E = HFD+600 mg/kg body weight SBE 
(Third treatment), F = HFD+1200 mg/kg body weight SBE (Fourth treatment)).
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indices with blood lipid profiles in the animals. 
Significant positive and negative associations were 
observed among the parameters. While there was a 
positive relationship between body weight gain 
and HDL-phospholipid (r = 0.403; p = 0.027), 
there was a negative association between 
atherogenic and coronary risk indices and HDL-
phospholipid (r = -0.722 and r = -0.726 at p = 
<0.001 respectively). The reverse was observed 
for erythrocyte cholesterol level. It positively 
correlated with atherogenic and coronary risk 
indices and negatively associated with body 
weight gain of  animals significantly.
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Fig. 7. Coronary Risk and Atherogenic Indices of  Animals. 
Bars carrying different letters of  the alphabet are significantly different from each other at p < 0.05. (A = 
Normal Control, B = Obese control,   C = HFD+150 mg/kg body weight SBE (First treatment), D = 
HFD+300 mg/kg body weight SBE (Second treatment), E = HFD+600 mg/kg body weight SBE 
(Third treatment), F = HFD+1200 mg/kg body weight SBE (Fourth treatment)).
There was a negative correlations between HDL-
cholesterol and atherogenic and coronary risk 
indices (r = -0.894 and = -0.878 at p = <0.001). 
Aside this, the indices associated positively with 
the plasma and VLDL+LDL lipid profiles and 
selectively associated with erythrocyte cholesterol 
and phospholipid. Among these significant 
associations, the highest positive significant 
association was observed between atherogenic 
index and VLDL+LDL-triacyglycerol while the 
lowest positive association was with plasma 
cholesterol (p < 0.05). 
DISCUSSION
Obesity is a global health problem which is related 
to several disease conditions including 
cardiovascular disease and diabetes (Shick et al., 
1998; Awika and Rooney, 2004; Dwivedi and 
Dwivedi, 2007). Due to this, a number of  weight 
loss regimens which include diets, pill and so on 
has emerged (Awika and Rooney, 2004). However, 
these regimens do not seem to produce desired 
effects and obesity cases continue to be on the 
increase (Shick et al., 1998; Hill et al., 2003; Wyatt, 
2003). Consumption of  food with high calorie 
and a lifestyle that lack physical activity account 
for most obesity cases (Awika and Rooney, 2004). 
However, the expected change in either of  these 
factors, as demanded by many weight loss 
strategies, is not easily sustained for long periods 
of  time, hence the failure of  these strategies to 
produce that desired impact on obesity (Shick et 
al., 1998; Awika and Rooney, 2004). The use of  
traditional medicines and/or medicinal plants for 
the maintenance of  good health in developing 
countries has been reported (UNESCO, 1998)  
and reports have shown that about 80% of  the 
population of  developing countries rely on 
traditional medicines like Sorghum bicolor for, for 
their primary health care (Schmincke, 2003).
From this study, it was observed that SBE 
administration was effective in reducing the body 
fat mass as depicted by reduced weight gain and 
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Lee index. This is in agreement with the findings 
of  Lizardo et al. (1995); Al-Mamary et al. (2001); 
Muriu et al. (2002) and Tsuda (2003) that some 
functional food components of  sorghum reduced 
body weight gain and adipose tissue weight. Tsuda 
(2003) provided evidence that anthocyanins 
present in S. bicolor inhibited increases in both 
body weight and adipose tissue weight of  rats 
consuming high-fat diets and then suggested that 
anthocyanins should be used as a functional food 
component in order to aid the prevention of  
obesity. On the other hand, Lizardo et al. (1995); 
Al-Mamary et al. (2001) and Muriu et al. (2002) 
recorded reduced weight gain in animals fed 
Parameter                            Correlation coefficient                                  P-value 
Body weight gain vs. 
Plasma phospholipids   -0.441     0.015 
HDL-phospholipids   0.403     0.027 
VLDL+LDL phospholipids  -0.524     0.003 
RBC cholesterol   -0.620     <0.001  
 
Atherogenic index vs. 
 
Plasma cholesterol   0.374     0.042 
Plasma triacylglycerol   0.540     0.002 
Plasma phospholipids   0.431     0.017  
HDL-cholesterol   -0.894     < 0.001 
HDL-phospholipids   -0.722     < 0.001 
VLDL+LDL triacylglycerol  0.923     < 0.001 
VLDL+LDL phospholipids  0.785     < 0.001 
VLDL-cholesterol   0.527     0.003 
LDL-cholesterol   0.816     < 0.001 
RBC cholesterol   0.683     < 0.001 
RBC phospholipids   0.538     < 0.001 
 
Coronary risk index vs. 
Plasma cholesterol  ` 0.449     0.013 
Plasma triglycerides   0.571     0.001 
Plasma phospholipids   0.465     0.010 
HDL-cholesterol   -0.878     <0.001 
HDL-phospholipids   -0.726     < 0.001 
VLDL+LDL triglycerides  0.902     < 0.001 
VLDL+LDL phospholipids  0.817     < 0.001 
VLDL-cholesterol   0.555     0.001 
LDL-cholesterol   0.733     < 0.001 
RBC cholesterol   0.719     < 0.001 
RBC phospholipids   0.616     < 0.001 
Table 4: Intensity of  Associations between Body Weight Gain, Atherogenic and Coronary Risk 
Indices with Blood Lipid Profiles in the Animals
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tannin-rich sorghum. Tannin sorghums carried 
out this mechanism by directly binding to digestive 
enzymes such as sucrase, amylases, trypsin, 
chymotrypsin and lipases, thus inhibiting their 
activity (Lizardo et al., 1995; Carmona et al., 1996; 
Nguz et al., 1998; Al-Mamary et al., 2001). 
Another finding of  this study is that treatment 
with SBE lowered the elevated cholesterol levels in 
plasma, LDL and erythrocyte while significantly 
increasing the level in HDL. These results 
corroborate the findings of  other researchers 
(Carr et al., 2005; Cho et al., 2008; Hoi et al., 2009; 
Chung et al., 2010; Kim and Park, 2012) that SBEs 
have cholesterol-lowering properties. This finding 
indicates that SBE possesses antilipidemic 
property and might be useful in the treatment of  
cardiovascular diseases since elevated levels of  
plasma and LDL- cholesterol have been associated 
with increased risk of  the diseases, whereas 
increase in HDL cholesterol is known to reduce 
the risk of  cardiovascular diseases (Kwiterovich, 
2000). Cho et al. (2008) and Chung et al. (2010) 
reported that Sorghum hexane extracts inhibited 
rat liver microsomal 3-hydroxy-3-methylglutaryl 
CoA (HMG CoA) reductase in a dose-dependent 
manner and also stated that fecal bile acid 
excretion, as well as levels of  HDL cholesterol was 
increased, when whole sorghum, was fed to rats at 
30% of  diet. Our result however disagreed with 
that of  Rooney et al. (1992) where blood serum 
total cholesterol was increased in rats fed sorghum 
bran. This may be due to the interference of  some 
components of  the extract with the metabolism 
of  these lipids.  
The presence of  saponins and flavonoids in plant 
extract has been reported to be responsible for the 
antilipidemic property of  the leaf  sheath (Cheeke, 
1971). Saponins are antinutritional factors which 
bind to cholesterol to form an insoluble complex 
and they have been reported to also bind 
endogenous cholesterol excreted through bile to 
prevent reabsorption of  cholesterol which 
ultimately leads to reduction in serum cholesterol 
(Rosen and MacDougald, 2006; Lai et al., 2009). 
From our results on levels of  phytochemicals in 
SBE (Table 2), saponins had the highest 
proportion of  31% of  the total phytochemicals. 
This suggests that SBE was able to decrease the 
levels of  lipid in the blood compartments through 
the mechanism of  inhibiting the activity of  the 
enzyme, HMG CoA reductase in cholesterol 
synthesis (Cho et al., 2008; Chung et al., 2010). 
SBE was also shown to reverse the increased 
levels of  triacylglycerol in plasma, erythrocyte, 
HDL and VLDL+LDL. Our result on plasma 
triacylglycerol supports the report by Kim and 
Park (2012), that sorghum extract significantly 
decreased concentration of  triglycerides in 
streptozotocin-induced diabetic rats. However, 
no report was made concerning the other blood 
compartments. This finding indicates that SBE 
could be thermogenic and therefore probably be 
able to aid in the combustion of  calories. It could 
also possibly affect the differentiation of  
adipocytes negatively thereby decreasing 
adipogenicity and fat cell formation by decreasing 
the expression of  fatty acid synthesis genes as well 
as activating the β-oxidation genes (Athesh et al., 
2012). 
The phospholipid levels in the plasma, HDL, 
VLDL+LDL and erythrocytes were elevated by 
high fat feeding, which was reduced by the oral 
administration of  the extract. Obesity is linked to 
chronic inflammation, and altered cell-mediated 
immune responses are affected by multiple 
mechanisms, due to a positive feedback loop 
between local inflammation in adipose tissue and 
dysregulated immune cell activation on one side 
and production of  pro-inflammatory mediators, 
such as leptin on the other (Benson et al., 2013). 
The modulation of  inflammatory status by 
bioactive constituents, particularly those present 
in common and traditional medicinal foods, is 
becoming an important factor in global 
preventive health management. Lee and Pan 
(2003) found that the sorghum residues 
significantly improved erythrocyte membrane 
integrity of  fish blood cells during winter, thus 
maintaining normal blood fluidity and preventing 
RBC hemolysis induced by H O . They also 
2 2
suggested that the prevention of  RBC hemolysis 
is due to the antioxidant activity of  the tannins 
and other polyphenols present in the sorghum 
residue. The lipid composition of  erythrocytes is 
now of  great interest, as the aetiology of  many 
diseases has been linked to erythrocyte lipid 
abnormalities (Allen and Manning, 1994). Several 
studies have shown that erythrocyte lipid is 
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composed mostly of  unesterified (free) 
cholesterol, phospholipids and little cholesterol 
esters which are different from that of  the plasma 
environment (Suda et al., 2002). The erythrocyte 
membranes are basically made up the 
phospholipids which play a major role in the 
integrity of  the membrane. Our results indicate a 
decreased fluidity in the erythrocytes of  the obese 
rats considering the cholesterol to phospholipid 
ratio (result not shown) while the SBE-treated 
groups had more normal blood fluidity and the 
effects of  pro-inflammatory mediators observed 
in obesity were prevented. This could be due to the 
antioxidant property of  the SBE as it contained 
flavonoids, phenols and tannins which have been 
reported to have antioxidant properties (Awika 
and Rooney, 2004). 
According to this study, SBE reduced the risk of  
the development of  coronary and atherogenic 
diseases as depicted by decreased coronary risk 
and atherogenic indices in the treatment groups. 
LDL levels are not consistently increased in 
obesity; it is smaller and denser and more 
atherogenic. It can be suggested that SBE acts by 
reducing the synthesis of  LDL and elevating that 
of  HDL, thus reducing the risk of  development 
of  cardiovascular diseases. The consumption of  
whole grains (like sorghum) is associated with a 
decrease in the incidence of  cardiovascular events 
(Jyothsna1 and Kumar, 2015). These two 
lipoproteins are involved in the transportation and 
metabolism of  lipids especially cholesterol. While 
LDL transports cholesterol to the peripheral 
tissues thereby increasing risk of  cardiovascular 
disease, HDL scavenges cholesterol from the 
peripheral tissues back to the liver for excretion 
through conversion to bile and negating the risk 
of  developing cardiovascular  diseases 
(Kwiterovich, 2000). The reduction of  LDL- 
cholesterol is attributed to the presence of  
saponins in the extract (Cheeke, 1971), whereas 
the increase in HDL-cholesterol is as a result of  
the presence of  flavonoids and phenols in the 
plant extract (Cheeke, 1971; Baba et al., 2007). 
Obesity increases VLDL (triacylglycerols) 
through increased production and decreased 
clearance of  triacylglycerols-rich lipoproteins due 
to lack of  stimulation of  lipoprotein lipase. So 
SBE could probably decrease triacylglycerol by 
increasing the stimulation of  lipoprotein lipase 
(Sandkamp et al., 1990; Sikaris, 2004). Cholesterol 
ester transport protein (CETP) exchanges 
triacylglycerols from VLDL to LDL in exchange 
for cholesterol esters. These result in 
triacylglycerol-rich LDL particles that are rapidly 
hydrolyzed by hepatic lipase leaving smaller 
denser LDL particles which can be oxidised or 
glycated possibly leading to less identification by 
the LDL receptor and decreased clearance in 
obesity. CETP also exchanges triacylglycerols 
from VLDL to HDL in exchange for cholesterol 
esters. This similarly results in triacylglycerol-rich 
HDL particles that are rapidly hydrolyzed by 
hepatic lipase allowing HDL to be cleared from 
the circulation (Sikaris, 2004). However, with the 
use of  SBE, the atherogenic LDL particles could 
have been both prevented from being oxidized or 
glycated, and therefore easily cleared from the 
system probably by increased recognition by the 
receptors, hence the decrease in LDL lipid 
concentrations observed in our results.
It could therefore be concluded based on the 
present findings that SBE is effective in 
ameliorating dyslipidemia associated with diet-
induced obesity and could probably be useful in 
managing obesity especially at the highest dose of  
1200 mg/kg body weight which proved to be 
most effective.
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